Viewing Study NCT05217108


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2025-12-31 @ 1:07 PM
Study NCT ID: NCT05217108
Status: RECRUITING
Last Update Posted: 2025-11-14
First Post: 2022-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Overview

Official Title: A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study
Status: RECRUITING
Status Verified Date: 2025-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To learn if an 8-week, phone-based texting intervention program will reduce sedentary (non-mobile) behavior.
Detailed Description: Primary Objective: To test the effect of two text messaging strategies, responsive texts and standard scheduled texts, on sedentary behavior in a racially and geographically diverse sample of adults.

Secondary Objective: To assess participant engagement with the program and with the educational content delivered via text messaging.

Exploratory Objective: To determine whether two text messaging strategies, responsive texts and standard scheduled texts, increases physical activity in a racially and geographically diverse sample of adults.

Exploratory Objective: To determine whether two text messaging strategies, responsive texts and standard scheduled texts are associated with changes in corresponding patient attitudes as assessed by surveys of exploring sedentary behavior, readiness for exercise change, and physical functioning.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
NCI-2022-00101 OTHER NCI CTRP Clinical Trials Registry View